Programmatic management of latent tuberculosis infection in the European Union
Programmatic management of latent tuberculosis infection (LTBI) is a key component of the global tuberculosis (TB) elimination strategy. This document provides evidence-based guidance for the implementation of programmatic management of LTBI in the European Union and European Economic Area (EU/EEA).
Interventions for improving adherence to treatment for latent tuberculosis infection: A systematic review
Stuurman, A.L., Vonk Noordegraaf-Schouten, M., van Kessel, F., Oordt-Speets, A.M., Sandgren, A., van der Werf, M.J.
Initiation and completion rates for latent tuberculosis infection treatment: A systematic review
Sandgren, A., Vonk Noordegraaf-Schouten, M., van Kessel, F., Stuurman, A., Oordt-Speets, A., van der Werf, M.J.
Management of latent tuberculosis infection
When people with infectious tuberculosis (TB) cough, sneeze or otherwise exhale droplets, they expose others to Mycobacterium tuberculosis. After a person is exposed, they can be infected with M. tuberculosis without having TB disease and without signs and symptoms. This is called latent TB infection (LTBI).